Expert faculty shine the spotlight on chronic rhinosinusitis with nasal polyps (CRSwNP), a disease associated with well-documented medical, psychological, social, and economic burdens. Using a case-based approach, faculty provide practical recommendations on how to best evaluate a patient’s symptoms, including the use of biomarkers to identify disease phenotypes and endotypes that can shape management decisions. Faculty examine various traditional medical and surgical treatments of CRSwNP, as well as indications for the use of biologic agents.
After completing this activity, the participant should be better able to:
The educational design of this activity addresses the needs of allergy, immunology, and otolaryngology specialists involved in the treatment of patients with CRSwNP.
There is no fee for this educational activity.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was released on November 13, 2020 and is valid for 1 year. Requests for credit must be made no later than November 13, 2021.
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
In order to receive credit for this activity, the participant must review the activity, complete and receive at least a 70% score on the posttest, and complete the evaluation form.
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox
MAC OS 10.2.8
Internet Explorer is not supported on the Macintosh.